Dongyi He
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies 28
- Systemic Lupus Erythematosus Research 14
- Spondyloarthritis Studies and Treatments 11
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis 4
- Cancer Research top 10%
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research 16
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 6
-
- Cytokine Signaling Pathways and Interactions 6
-
- Chronic Lymphocytic Leukemia Research 6
- Journals
- Frontiers in Immunology (7 papers)Clinical Rheumatology (5 papers)Annals of the Rheumatic Diseases (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Dongyi He
54 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Rheumatology 602
- Immunology 511
- Cancer Research 295
- Hematology 189
- Pathology and Forensic Medicine 133
Countries citing papers authored by Dongyi He
This map shows the geographic impact of Dongyi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongyi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongyi He more than expected).
Fields of papers citing papers by Dongyi He
This network shows the impact of papers produced by Dongyi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongyi He. The network helps show where Dongyi He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dongyi He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | Macrophage polarization in rheumatoid arthritis: signaling pathways, metabolic reprogramming, and crosstalk with synovial fibroblastsbreakdown → | 2024 | 65 |
| 5 | 2024 | 14 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 12 | |
| 9 | 2023 | 9 | |
| 10 | 2021 | 9 | |
| 11 | 2019 | 9 | |
| 12 | Shared HLA Class I and II Alleles in Susceptibility to Ankylosing Spondylitis Among Three Ethnic Groups. | 2014 | 1 |
| 13 | 2014 | 27 | |
| 14 | 2012 | 40 | |
| 15 | The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-αbreakdown → | 2012 | 369 |
| 16 | 2011 | 15 | |
| 17 | 2011 | 44 | |
| 18 | 2010 | 69 | |
| 19 | 2010 | 96 | |
| 20 | 2007 | 17 |
About Dongyi He
Dongyi He is a scholar working on Rheumatology, Hematology, Immunology, Genetics and Pathology and Forensic Medicine, having authored 56 papers that have together received 1.5k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (28 papers), Autoimmune and Inflammatory Disorders Research (16 papers), Systemic Lupus Erythematosus Research (14 papers), Spondyloarthritis Studies and Treatments (11 papers), Cytokine Signaling Pathways and Interactions (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). The work is most often cited by research in Rheumatology (602 citations), Immunology (511 citations), Cancer Research (295 citations), Hematology (189 citations) and Pathology and Forensic Medicine (133 citations). Dongyi He has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jingwu Z. Zhang, Wen Pan, Yuanjia Tang, Yufang Shi, John B. Harley, Honglin Wang, Yan Liu, Xinrui Shao, Wenjun Liu and Xinyang Song. Their work appears in journals such as Frontiers in Immunology, Clinical Rheumatology, Annals of the Rheumatic Diseases, Scientific Reports and Therapeutic Advances in Musculoskeletal Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.